一个TiME的问题:微环境相互作用如何塑造CLL和里希特转换中的免疫治疗反应
Alexander F Vom Stein1,2,3, Phuong-Hien Nguyen1,2,3, Elisa Ten Hacken4
1Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Frontiers in immunology
|June 13, 2025
概括
免疫疗法在里希特转换 (RT) 和慢性淋巴细胞白血病 (CLL) 中表现有前途,但面临挑战. RT和CLL之间的瘤免疫微环境 (TiME) 的差异影响治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 免疫疗法改变了癌症的治疗方法,包括B细胞淋巴瘤.
- 虽然对里希特转换 (RT) 有效,但免疫疗法在慢性淋巴细胞白血病 (CLL) 中表现出有限的活性.
- 瘤免疫微环境 (TiME) 和细胞相互作用的差异可能解释了RT与CLL的不同反应.
研究的目的:
- 审查CLL和RT中的瘤免疫微环境 (TiME).
- 为了比较CLL和RT中的TiME组成和相互作用.
- 讨论当前免疫疗法临床试验以及对CLL和RT的未来研究方向.
主要方法:
- 对CLL和RT中TiME最近的研究进行分析.
- 包括来自患者的组织的数据.
- 考虑新型小鼠模型的发现.
主要成果:
- 在CLL和RT之间的TiME中存在显著差异.
- 这些微环境变化会影响免疫疗法的疗效.
- 与CLL相比,目前的免疫疗法在RT中表现出不同的活性.
结论:
- 了解TiME差异对于优化CLL和RT免疫疗法至关重要.
- 需要进一步的研究来克服挑战并改善治疗结果.
- 未来的战略应侧重于根据特定的TiME特征量身定制免疫疗法.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
T Cell Activation and Clonal Selection
691
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
691


